Expand this Topic clickable element to expand a topic
Skip to content
Optica Publishing Group
Conferences > CLEO_Europe > 2000 > CThI > CThI1
  • Conference on Lasers and Electro-Optics Europe
  • Technical Digest Series (Optica Publishing Group, 2000),
  • paper CThI1

Photodynamic Therapy in the Treatment of Age Related Macular Degeneration. An Update on Currently Ongoing Studies with Verteporfin (TAP/VIP trial)

I. Barbazetto

Not Accessible

Your library or personal account may give you access

Abstract

The aim of these studies was to determine if photodynmaic therapy with Vertepofin can safely reduce the risk of vision loss in patients with subfoveal, choroidal neovascularization (CNV) secondary to age related macular degeneration (TAP trial) and pathologic myopia (VIP trial).

© 2000 IEEE

PDF Article
More Like This
Photodynamic Therapy for Treatment Subretinal Neovascularization

Sergey E. Avetisov, Maria V. Budzinskaja, Tatyana N Kiseleva, Natalia V. Balatskaya., Irina V. Gurova., Victor B. Loschenov, Sergey A. Shevchik, Sergey G. Kuzmin, and Georgy N. Vorozhtsov
6632_63 European Conference on Biomedical Optics (ECBO) 2007

Photodynamic Therapy (PDT) in the Treatment of Choroidal Neovascularization

Ursula M. Schmidt-Erfurth
CWA1 Biomedical Topical Meeting (BIOMED) 1999

Infrared Imaging in Age-Related Macular Degeneration: Retinal Pigment Epithelial Detachments

Ann E. Elsner, Giovanni Staurenghi, John J. Weiter, Sheldon M. Buzney, Sebastian Wolf, and Kenneth J. Wald
NMB.5 Noninvasive Assessment of the Visual System (NAVS) 1993

View More...
Select as filters
Select Topics Cancel
Top
       
© Copyright 2024 | Optica Publishing Group. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
Privacy | Terms of Use